Le Lézard
Classified in: Health
Subject: PER

Echolight announces new executive hires


SEATTLE, Nov. 25, 2020 /PRNewswire/ -- On the heels of its recent US launch, Echolight Medical announces the hiring of several industry heavyweights, not only in radiology but specifically in point-of-care service. Seattle-based Gina Raebel is VP of Marketing. Florida-based Alex Exposito is VP of Sales. Washington-based Bryan Vick is VP of Operations & Customer Service. Headshots available here.

"Echolight is focused on moving bone density measurement and monitoring to the point-of-care to treat patients faster, more accurately, and in a non-invasive way, without relying on costly and time-consuming trips to the radiology department," explained Raebel, who most recently worked with Fujifilm Sonosite as Senior Director, Global Marketing and has spent more than a decade bringing advanced medical imaging technologies to the point-of-care. "Echolight's portable EchoS allows health care professionals to quickly diagnose and monitor patients wherever they are being treated."

More than half of the U.S. population is impacted by osteoporosis and low bone mass. Increased screening is essential to reducing fracture rates and must be more accessible to both patients and their point-of-care providers. Echolight seeks to position primary care physicians and private health and wellness professionals as frontline providers of bone density screening and monitoring at their practices.

Exposito is working with thought-leading doctors, hospitals, universities, coaches, nutritionists and other early adopters across the country to introduce "technology that is going to transform the way we look at bone health," he says. Having begun his career as a sonographer, Exposito has nearly 30 years experience in the field, most recently as Director, Strategic Accounts with Hologic. With success leading national and international teams driving sales of new ultrasound systems, medical devices, and capital equipment, Exposito is accustomed to building sales organizations for  start-ups and for new product launches. "EchoS is poised to be the new standard for measuring bone density and assessing fracture risk."

Vick is a customer-focused technical support leader with nearly 25 years of medical device experience. He most recently served 16+ years with Fujifilm Sonosite where he oversaw worldwide technical support for an installed base in excess of 60,000 units. Vick was with TriPath Imaging for eight years - four in manufacturing, four in service. Vick also served for six years in the United States Navy as an electronics technician and nuclear reactor operator. Vick said, "It's fulfilling to work among such a highly qualified team, and with a medical device that we all believe will transform a facet of healthcare."

About EchoS: Portable, diagnostic, radiation-free bone health densitometer - a safe, accurate, and cost-effective medical device elevating bone health awareness and treatment to mainstream medical care. FDA-cleared, EchoS uses Radiofrequency Echographic Multi Spectrometry (R.E.M.S.) to measure Bone density and provides T-score, Z-score, and a qualitative assessment of bone microarchitecture, independent of bone density, to predict future fracture risk. All provided in minutes. Learn more at EcholightMedical.com.

Contact:
Jesse Landis
813.846.3167 (cell)
[email protected]  

SOURCE Echolight Medical


These press releases may also interest you

at 18:24
The scheduled merits hearing dates, April 26 and 29, 2024, in the above-named matter will proceed by videoconference. On April 26, 2024, the hearing will commence 11:15 a.m. Members of the public may observe the hearing by videoconference, by...

at 17:55
Valeo Pharma Inc. ("Valeo" or the "Company"), a Canadian pharmaceutical company, today announced the results of the matters submitted to shareholders at its annual meeting of shareholders held on April 25, 2024 (the "Meeting")....

at 17:43
Community Healthcare Trust Incorporated today announced that its Board of Directors has increased its common stock cash dividend for the quarter ended March 31, 2024. This dividend, in the amount of $0.46 per share, is payable on May 24, 2024 to...

at 17:31
DelveInsight's Urine Output Monitoring Systems Market Insights report provides the current and forecast market analysis, individual leading urine output monitoring systems companies' market...

at 17:00
Enghouse Video, a global leader in cutting-edge video technology solutions, today announced its partnership with SONIFI Health, enhancing virtual care in hospital settings. SONIFI Health is a leading U.S. healthcare technology company based in Sioux...

at 17:00
A record 3,618 graduating students and physicians matched to residency training programs in Canada in this year's R-1 Main Residency Match (R-1 match), the Canadian Resident Matching Service (CaRMS) announced today....



News published on and distributed by: